Dosimetric Evaluation of Permanent Prostate Brachytherapy Using Cs-131 Sources

Cancer types prostate


Steven Kurtzman, M.D

International Journal of Radiation Oncology Biology Physics
November 1, 2006
Dr. Kurtzman, of San Mateo, California, studied the dosimetry of 58 patients implanted with Cs-131. He noted the dose “inhomogeneity” – as measured by the dosimetric concept “V150” – to be very low as compared to other brachytherapy isotopes.

Related posts

Scroll to top